Self-funded plans pay full price.
We find where they don't have to.
You carry every claim dollar directly. There's no insurer buffer, no pooled risk — just your plan, your members, and your budget. Most self-funded employers never get a clear look at where lower-cost drug alternatives exist.
What we look at
We review your plan's drug exposure against generic equivalents and therapeutic alternatives — medications that treat the same condition at significantly lower cost.
Generic Equivalents
Same active ingredient, significantly lower cost.
Therapeutic Alternatives
Clinically comparable medications in the same class.
Prior Authorization
We flag requirements so you know what needs a PBM conversation.
What you get
A plain-language report covering the critical data points your benefits team needs to take action.
Drug Classes
Identify which classes have lower-cost generic or therapeutic alternatives.
Savings Ranges
Get estimated savings ranges specifically calculated for your plan size.
PA Requirements
Detailed prior authorization requirements for every identified alternative.
Actionable Focus
Ranked opportunities by likely financial and clinical impact.
Who this is for
This is decision-support for your team — not a mandate to change.
Employers
Self-funded employers who want more transparency into where their drug dollar goes.
Brokers
Benefits brokers and consultants looking to bring sharper analysis to renewal conversations.
TPAs
Third-Party Administrators adding concrete cost-management services for clients.
One honest caveat: We're an analytics service, not a clinical decision tool. Alternatives that look good on paper may not be appropriate for every member. Our job is to surface the options and the tradeoffs — your clinical and benefits advisors make the calls.
Savings estimates are ranges. Actual results depend on your claims mix, PBM contract terms, and rebate arrangements.
Learn where your plan is overpaying
Get a clear look at where your plan could be saving money without sacrificing clinical quality. Our team will reach out to discuss your plan size and drug mix.